Last ¥316.00 JPY
Change Today +1.00 / 0.32%
Volume 522.5K
As of 2:00 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

medibic group (2369) Snapshot

Open
¥318.00
Previous Close
¥315.00
Day High
¥324.00
Day Low
¥315.00
52 Week High
10/9/13 - ¥541.00
52 Week Low
08/1/13 - ¥207.00
Market Cap
9.2B
Average Volume 10 Days
568.3K
EPS TTM
¥-12.52
Shares Outstanding
29.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIBIC GROUP (2369)

Related News

No related news articles were found.

medibic group (2369) Related Businessweek News

No Related Businessweek News Found

medibic group (2369) Details

MediBIC Group, Co., Ltd. operates as a biotechnology company that specializes in pharmacogenomics (PGx). The company operates in three segments: The Biomarker Drug Discovery, Personalized Healthcare Management Support, and Cancer Drug Development. The Biomarker Drug Discovery segment provides various solution services for new drug development, including PGx project planning, sample collection arrangement, sample logistic, sample banking, DNA/RNA extraction and analysis, and data analysis for biomarker discovery of drug development; and development support products. The Personalized Healthcare Management Support segment offers Genetic Testing for Drug Response, a DNA screening test designed for individuals to find out if his/her genetics would affect excessive response to some drugs; and a test designed for newborn babies to obstetricians. The Cancer Drug Development segment develops glufosfamide, a small molecule indicated for the treatment of various cancer types. The company serves pharmaceutical companies, research institutes, and universities. MediBIC Group, Co., Ltd. was founded in 2000 and is headquartered in Tokyo, Japan.

21 Employees
Last Reported Date: 03/27/14
Founded in 2000

medibic group (2369) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medibic group (2369) Key Developments

MediBIC Group, Co., Ltd. to Report Q1, 2014 Final Results on May 13, 2014

MediBIC Group, Co., Ltd. announced that they will report Q1, 2014 final results on May 13, 2014

MediBIC Group, Co., Ltd., Annual General Meeting, Mar 25, 2014

MediBIC Group, Co., Ltd., Annual General Meeting, Mar 25, 2014.

MediBIC Group, Co., Ltd. to Report Fiscal Year 2013 Results on Feb 13, 2014

MediBIC Group, Co., Ltd. announced that they will report fiscal year 2013 results on Feb 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2369:JP ¥316.00 JPY +1.00

2369 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2369.
View Industry Companies
 

Industry Analysis

2369

Industry Average

Valuation 2369 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 39.1x
Price/Book 8.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 37.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIBIC GROUP, please visit www.medibic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.